We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GILD Gilead Sciences Inc

1.18 (1.51%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 6,568,627
Bid Price 77.53
Ask Price 79.23
News -
Day High 79.24


52 Week Range


Day Low 77.94
Share Name Share Symbol Market Stock Type
Gilead Sciences Inc GILD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.18 1.51% 79.23 19:00:00
Open Price Low Price High Price Close Price Previous Close
78.11 77.94 79.24 79.02 78.05
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
60,619 6,568,627 US$ 78.57 US$ 516,110,410 - 72.8659 - 89.74
Last Trade Type Quantity Price Currency
18:59:32 1 US$ 78.99 USD

Gilead Sciences (GILD) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Gilead Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
98.46B 1.25B - 27.28B 4.59B 3.69 21.44
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Gilead Sciences News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No GILD Message Board. Create One! See More Posts on GILD Message Board See More Message Board Posts

Historical GILD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week76.7880.1876.2078.456,836,9652.453.19%
1 Month75.4680.1873.9976.246,183,8813.775.0%
3 Months77.2182.5972.865976.965,834,8062.022.62%
6 Months75.7682.5972.865977.205,758,0803.474.58%
1 Year87.8789.7472.865980.005,899,242-8.64-9.83%
3 Years60.5689.7456.5669.877,261,89518.6730.83%
5 Years69.2289.7456.5669.718,299,88610.0114.46%

Gilead Sciences Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |